American CryoStem Opens Stem Cell Processing and Storage Laboratory
October 13 2011 - 6:54PM
Marketwired
American CryoStem Corporation (OTCBB: CRYO) is pleased to announce
the Opening of our FDA registered tissue processing facility,
located in Mount Laurel NJ. To date, the laboratory has processed
in excess of 100 adipose tissue samples for long term storage of
the adipose derived stem cells and regenerative cells.
American CryoStem's laboratory provides the highest quality
tissue processing and storage services, operating in conformity
with the PHS Act, current FDA regulations and guidance including
current Good Manufacturing Practice (cGMP) and current Good Tissue
Practice (cGTP).
In preparation for a timely submission for accreditation, we
have implemented the additional guidance and methodologies of the
American Association of Tissue Banks, The American Association of
Blood Banks, and FACT-JACIE.
Our proprietary processing and internal controls assure our
clients the highest quality services available which include:
perpetual chain of custody monitoring; multiple in-process
sterility and viability tests; recovery and bio-generation tests to
measure the expansion and differentiation abilities of each stored
client sample.
Anthony Dudzinski, Chief Operating Officer, stated, "We are
pleased and excited about the completion of our laboratory and the
introduction of our services to the market. We believe that our
internal standards exceed current regulatory protocol. Our goal is
to set the standard for the industry for the aseptic processing of
adipose tissue and provide the highest quality cellular samples.
Our proprietary cGMP/cGTP processing consistently yields large
volumes of uncontaminated regenerative cells that can be retrieved
by our clients at any time."
American CryoStem has developed collaborative relationships with
cosmetic, plastic, and orthopedic surgeons, as well as leading
scientists in the field of regenerative medicine. These
collaborations will help accelerate usage of individual stored
client samples in the fields of: cosmetic and plastic surgery (fat
transplantation, natural breast reconstruction and enhancement,
surgical scar healing); orthopedics (bone, muscle, and joint
repair); and cardiology (heart, artery and vein repair).
About American CryoStem: the Company markets a core clinical
processing platform for Adipose (fat) Derived Adult Stem Cells. The
Company's service provides for the collection, processing, and
cryopreservation (long term storage) of adult stem cells. This
allows healthy individuals to privately preserve their stem cells
for future use in personalized and regenerative medicine at an
affordable price. Adult Stem Cells treatments are currently being
utilized to potentially heal one's own body of diseases and chronic
conditions. The Company's proprietary platform provides a
streamlined and affordable, processing and cryopreservation of
Adipose Derived Stem Cells (ADSCs) and Adipose Tissue (AT) for
autologous (self) use.
Add to Digg Bookmark with del.icio.us Add to Newsvine
Contact: American CryoStem Corporation 188 East Bergen Place,
Suite 204 Red Bank, NJ 07701 732-747-1007
www.americancryostem.com
American Cryostem (CE) (USOTC:CRYO)
Historical Stock Chart
From Jun 2024 to Jul 2024
American Cryostem (CE) (USOTC:CRYO)
Historical Stock Chart
From Jul 2023 to Jul 2024